P1135 ADDITION OF TELAPREVIR OR BOCEPREVIR TO PEG-RIB THERAPY INCREASES THE RISK OF INFECTIONS IN PATIENTS WITH HEPATITIS C-RELATED CIRRHOSIS (HCV-CH): A COMPARATIVE STUDY

✍ Scribed by Londoño, M.-C.; Perelló, C.; Cabezas, J.; Carrión, J.-A.; Lens, S.; Mariño, Z.; Rodríguez, R.; Menéndez, S.; Crespo, J.; Calleja, J.-L.; Forns, X.

• Book ID: 122616418
• Publisher: Elsevier Science
• Year: 2014
• Tongue: English
• Weight: 99 KB
• Volume: 60
• Category: Article
• ISSN: 0168-8278
• DOI: 10.1016/S0168-8278(14)61295-2